Skip to Content
Merck
  • Controlled gene delivery can enhance therapeutic outcome for cancer immune therapy for melanoma.

Controlled gene delivery can enhance therapeutic outcome for cancer immune therapy for melanoma.

Current gene therapy (2014-11-22)
Shawna A Shirley, Cathryn G Lundberg, Fanying Li, Niculina Burcus, Richard Heller
ABSTRACT

Effective delivery still remains a major hurdle in the development of gene based therapies. While technological advances have occurred that have improved delivery in general, there is still a need for controlled delivery in order to achieve therapeutic effects. Gene electrotransfer (GET) can be utilized to accomplish this. Careful selection of parameters used for delivery such as amplitude, duration and number of pulses as well as plasmid construct can be manipulated in order to achieve appropriate levels of local expression. Previously we have shown that direct delivery of the therapeutic cytokine, interleukin 12 (IL-12), to tumors using electrotransfer can generate local and systemic anti-tumor effects in pre-clinical and clinical studies. Using this model we hypothesized that modulating local gene expression using GET can affect therapeutic outcome. To test this, we used multiple GET protocols and plasmids to achieve varying levels of local IL-12 expression. We found that high local gene expression did not give rise to a better therapeutic outcome. This suggests the level and possibly the duration of gene expression are important in mediating the host immune response against melanoma. These data also emphasize the importance of considering the desired immune outcome of the therapy when selecting parameters for GET.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethanol, ≥99.5%
Sigma-Aldrich
Ethanol, JIS 300, ≥99.5%, for residue analysis
Sigma-Aldrich
Ethanol, JIS 1000, ≥99.5%, for residue analysis
Sigma-Aldrich
Ethanol, ≥99.5%, suitable for absorption spectrum analysis
Sigma-Aldrich
Ethanol, ≥99.5%, suitable for HPLC
Sigma-Aldrich
Ethanol, ≥99.5%, suitable for fluorescence
Sigma-Aldrich
Ethanol, ≥99.5%, SAJ super special grade
Sigma-Aldrich
Ethanol, JIS special grade, ≥99.5%
Sigma-Aldrich
Ethanol, SAJ first grade, ≥99.5%
Sigma-Aldrich
Ethyl alcohol, Pure, 190 proof, ACS spectrophotometric grade, 95.0%
Supelco
Ethanol standards 10% (v/v), 10 % (v/v) in H2O, analytical standard
Sigma-Aldrich
Ethanol, puriss. p.a., absolute, ≥99.8% (GC)
Sigma-Aldrich
Ethanol, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Ethyl alcohol, Pure 200 proof, for molecular biology
Sigma-Aldrich
Acetone, for chromatography, ≥99.8%
Sigma-Aldrich
Ethanol, 94.8-95.8%
Sigma-Aldrich
Acetone, JIS special grade, ≥99.5%
Sigma-Aldrich
Acetone, SAJ first grade, ≥99.0%
Sigma-Aldrich
Acetone, for residue analysis, JIS 5000
Sigma-Aldrich
Acetone, suitable for HPLC
Sigma-Aldrich
Acetone, ≥99.5%, for residue analysis
Sigma-Aldrich
Acetone, for residue analysis, ≥99.5%
Sigma-Aldrich
Ethanol, JIS special grade, 94.8-95.8%
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
Supelco
Acetone, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acetone, suitable for HPLC, ≥99.9%
Supelco
Acetone, analytical standard
Sigma-Aldrich
Acetone, natural, ≥97%
Sigma-Aldrich
Acetone, ≥99%, meets FCC analytical specifications
Sigma-Aldrich
Ethanol Fixative 80% v/v, suitable for fixing solution (blood films)